# Travere Therapeutics, Inc. Common Stock (TVTX)

Travere Therapeutics faces FDA information request on FILSPARI efficacy, causing price drops despite analyst upgrades. Regulatory uncertainty is the primary driver of current market sentiment.

### About Travere Therapeutics, Inc. Common Stock
Travere Therapeutics, Inc. is a pharmaceutical company focused on developing therapies for rare diseases.  
Travere Therapeutics, Inc. Common Stock uses the ticker $TVTX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Travere Therapeutics, Inc. Common Stock (TVTX) social dominance is up 93.75% from the previous week.
- Travere Therapeutics, Inc. Common Stock (TVTX) creators is up 47.89% from the previous week.
- Travere Therapeutics, Inc. Common Stock (TVTX) engagements is up 48.08% from the previous week.
- Travere Therapeutics, Inc. Common Stock (TVTX) mentions is up 273.46% from the previous year.
- Travere Therapeutics, Inc. Common Stock (TVTX) posts created is up 33.33% from the previous week.

### Price: $27.80
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$tvtx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$tvtx/time-series/close.tsv)  
The stock is experiencing negative price action due to an FDA information request concerning FILSPARI's efficacy, leading to price drops despite some analyst upgrades. Regulatory uncertainty is driving negative market reaction.  

24-Hour: -8.46%
7-Day: -6.36%
30-Day: -0.18%

1-Year High: $40.30 on 2025-12-24  
1-Year Low: $13.50 on 2025-04-10  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$tvtx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$tvtx/time-series/alt_rank.tsv)  
Travere Therapeutics, Inc. Common Stock (TVTX) is currently AltRank #1,143 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] [----]  
[--] Month: [---] +329  
[--] Months: [---] +324  
[--] Year: [---] +426  
1-Year High: [-----] on 2026-01-26  
1-Year Low: [--] on 2025-11-22  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$tvtx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$tvtx/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +1  
[--] Month: [--] +5  
1-Year High: [--] on 2025-12-29  
1-Year Low: [--] on 2025-11-21  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$tvtx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$tvtx/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [------] +48%  
[--] Month: [-------] -70%  
[--] Months: [---------] +136%  
[--] Year: [---------] +108%  
1-Year High: [-------] on 2025-05-01  
1-Year Low: [---] on 2025-04-22  

Engagements by network (24h):
Reddit: [--]
YouTube: [--]
News: [--]
X: [-----]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$tvtx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$tvtx/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [--]  
[--] Week: [---] +36%  
[--] Month: [-----] +11%  
[--] Months: [-----] +103%  
[--] Year: [-----] +273%  
1-Year High: [---] on 2026-01-15  
1-Year Low: [--] on 2025-04-13  

Mentions by network (24h):
Reddit: [--]
YouTube: [--]
News: [--]
X: [---]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$tvtx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$tvtx/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Travere Therapeutics, Inc. Common Stock (TVTX) in the last [--] hours which is up 125% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +48%  
[--] Month: [---] +6.10%  
[--] Months: [-----] +16%  
[--] Year: [-----] +323%  
1-Year High: [---] on 2026-01-15  
1-Year Low: [--] on 2025-04-18  

The most influential creators that mention Travere Therapeutics, Inc. Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | [--]    | [-----]     | [--]     | [-----]       |
| [@CameronBoswell8](/creator/twitter/CameronBoswell8) | [--]    | [---]       | [--]     | [---]         |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]     | [---]         |
| [@daytrd247](/creator/twitter/daytrd247)             | [--]    | [--]        | [--]    | [---]         |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]     | [---]         |
| [@mariostario2019](/creator/twitter/mariostario2019) | [--]    | [--]        | [--]     | [---]         |
| [@Stock_Analysis2](/creator/twitter/Stock_Analysis2) | [--]    | [---]       | [--]     | [---]         |
| [@Trade_market6](/creator/twitter/Trade_market6)     | [--]    | [---]       | [--]     | [---]         |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [------]    | [--]     | [---]         |
| [@Trade_market120](/creator/twitter/Trade_market120) | [--]   | [--]        | [--]     | [---]         |

[View More](/list/creators/$tvtx/100)
  
  
### Sentiment: 44%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$tvtx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$tvtx/time-series/sentiment.tsv)  
Current Value: 44%  
Daily Average: 88%  
[--] Week: 100% no change  
[--] Month: 39% -24%  
[--] Months: 39% -61%  
[--] Year: 39% -43%  
1-Year High: 100% on 2025-02-21  
1-Year Low: 35% on 2025-12-16  

Most Supportive Themes:
- FDA Approval/Positive News: (45%) Positive sentiment surrounding the FDA's actions regarding the drug Filspari.
- Analyst Upgrades and Price Target Increases: (25%) Multiple analysts have upgraded Travere Therapeutics ($TVTX), increasing price targets and expressing positive outlooks.
- Strong Performance and Momentum: (20%) Posts highlight $TVTX as a top gainer, with significant price increases and mentions in various stock lists.
  
Most Critical Themes:
- Losses and Negative Sentiment: (5%) Some posts mention $TVTX as a loser or highlight negative aspects.
  
  
  
### Social Dominance: 0.00854%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$tvtx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$tvtx/time-series/social_dominance.tsv)  
Current Value: 0.00854%  
Daily Average: 0.01%  
[--] Week: 0.0062% +0.003%  
[--] Month: 0.016% -0.036%  
[--] Months: 0.016% +0.0064%  
[--] Year: 0.016% -0.0076%  
1-Year High: 0.052% on 2026-01-15  
1-Year Low: 0.0023% on 2025-04-18  
  
  
### Market Dominance: 0.00282%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$tvtx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$tvtx/time-series/market_dominance.tsv)  
Current Value: 0.00282%  
Daily Average: 0%  
1-Year High: 0.123% on 2026-02-06  
1-Year Low: 0.00282% on 2026-02-14  
  
  
### Market Cap: $2,489,120,137
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$tvtx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$tvtx/time-series/market_cap.tsv)  
Current Value: $2,489,120,137  
Daily Average: $2,984,227,112  
[--] Week: $2,506,119,879 -5.70%  
[--] Month: $2,489,120,137 -2%  
1-Year High: $3,603,945,332 on 2025-12-24  
1-Year Low: $2,458,699,546 on 2025-10-22  

### Top Travere Therapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"End of Day Laggers $ANPA $UPB $IRON $NVCR $SHMD $PLYX $BROS $BFAM $TWFG $AGCC $AKBA $FA $TVTX $SPSC $BNTC"  
[X Link](https://x.com/DayTraderTeam/status/2022427384289636698) [@DayTraderTeam](/creator/x/DayTraderTeam) 2026-02-13T21:47Z [---] followers, [---] engagements


"Conviction is through the roof $XPON $HOLO $MNTS $MNTSW $BNZI $SONDW $WW $KXIN $SRFM $ALTM $MYNZ $NUWE $CTCX $HOLOW $USAS $INHD $SPPL $SGN $MYND $BURU $KZR $SMXT $LVO $TVTX $WKSP $AGRI $RR $GOVX $MLGO $XHG $NVDA $AMC $AMZN $GOOGL $MULN $META $HUSA $GRTS $APDN $ICCT $PZA $HWH INSIDERS ARE LOADING $PROP WHY ISNT WALL STREET YET While most investors chase headlines the smart money inside Prairie Operating Co. has been quietly building massive positions. Key insiders control a significant chunk of the float Leadership and major holders own https://t.co/Y81oDJoJEm INSIDERS ARE LOADING $PROP WHY"  
[X Link](https://x.com/BuyTheUgly/status/2022345946890408058) [@BuyTheUgly](/creator/x/BuyTheUgly) 2026-02-13T16:23Z [--] followers, [---] engagements


"My watch list of catalysts- update 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD $PVLA Ph3 mLM My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC"  
[X Link](https://x.com/Andre_AGTC/status/2022077136581083568) [@Andre_AGTC](/creator/x/Andre_AGTC) 2026-02-12T22:35Z [----] followers, [----] engagements


"⚠       .  (  )  : $TRUE $APLT $DV $OR $TVTX $RSSS $NXGL $OOMA $IREN $ROAD #_ #_ http://t.me/Tawsiiatfalcon1 http://t.me/Tawsiiatfalcon1"  
[X Link](https://x.com/raheelmohmmed1/status/2022056513775579589) [@raheelmohmmed1](/creator/x/raheelmohmmed1) 2026-02-12T21:13Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing